New report urges more clinical trial diversity, recommends incentives

Regulatory NewsRegulatory NewsAPIsBiologicsBiotechnologyClinical TrialsCombination ProductsDiagnosticsEthicsMedical DevicesNorth AmericaOTCPharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and Development